COMMENTARY

• Lenvima Heading into Megablockbuster Territory, Will Merck Tie-Up Help It Top Combined Aricept/Pariet Sales?
  March 12, 2020

• Unison Capital Shows Rising Presence with Kyowa Deal, PE Fund Potential Catalyst for Industry Shakeup?
  November 22, 2019

• Finance Officials, Payers Grow Jittery as Xolair’s Pollen Allergy Nod Looms
  November 18, 2019

• Pharma’s Downsizing Bandwagon Shows No Sign of Slowing, Companies Seeking Even Leaner Staff
  October 28, 2019

• Pharma Should Tap Health Coverage Debate as Catalyst to Draw Govt’s Commitment on Innovation
  October 1, 2019

• After Death in First-in-Human Study, MHLW Needs to Release Info. to Alleviate Concerns about Participation in Studies
  August 26, 2019

• Generic Players Step Up Info Disclosure for Survival in Post-80% Era
  July 16, 2019

• Drug Pricing Debate for 2020 Reform Going into High Gear; Industry Leery of Post-Election Surprises
  July 5, 2019

• Filing for Sakigake Radiation Therapy Expected This Year for Head and Neck Cancer; Expanded Use, Overseas Development Eyed
  June 25, 2019

• Cell Therapy Makers Working to Stand Out from Rivals by Reducing Burdens on Hospitals
  April 16, 2019

• Building Credible, Convincing System Holds Key for Japan’s Cost-Effectiveness Assessment
  April 2, 2019

• Generic Makers Shifting to Focus on “Specialty Area” Faced with Tougher Business Environment
  March 4, 2019

• Restructuring, Divestment Progress in Wake of Drug Pricing Overhaul
  February 20, 2019

• 2019 Likely to Herald Burst of “Regenerative Medicine” Approvals
  January 11, 2019

• LDP Draws Up Tax Reform Outline, Revamps Credits for R&D Expenses
  December 17, 2018

• After Thumbs-Up Given to Shire Buy, Weber’s Leadership Will Now Be Put to Test
  December 12, 2018

• Does Dissolution of Japan Vaccine Signal Demise of Model in Vaccine Industry Vision, or Will a Second Round of JV Take Place?
  November 27, 2018

• There’s Room for Growth in Biosimilar Space, but Who Will Grab It?
  August 3, 2018

• Astellas/Daiichi Sankyo Showdown Looms as Their FLT3 Inhibitors Near Approval
  July 12, 2018

• LDP Heavyweights on Guard for Push to Scrap Coverage for Patch Medications
  July 5, 2018

ページ